A plant-based vaccine from a GlaxoSmithKline alliance with Medicago shows strong antibody response By: MarketWatch May 18, 2021 at 10:57 AM EDT Trial participants have 10 times more antibodies in their systems than patients recovering from COVID-19. Read More >> Related Stocks: Astrazeneca Plc ADR